Michael V. Seiden - Concepedia

Author

Michael V. Seiden

Also Known As

M SEIDEN, M Seiden, M V Seiden, M. SEIDEN, M. Seiden, M. V. Seiden, M.V Seiden, M.V. SEIDEN, M.V. Seiden, Michael Seiden

241

Publications

14K

Citations

H-Index

136

Concepts

All Affiliations

Massachusetts General Hospital Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Fox Chase Cancer Center

About

Michael V. Seiden is an author at Massachusetts General Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	63	3.9K
2	Health Sciences	10	10	492
3	Engineering	6	6	238
4	Public Health	4	4	86
5	Natural Sciences	1	1	22

Michael V. Seiden

116

Publications

11.7K

Citations

H-Index

Page 1

	Year	Citations
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein, Annals of Oncology	2020	1.4K
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients F. Stephen Hodi, Martín C. Mihm, Robert J. Soiffer, Proceedings of the National Academy of Sciences	2003	993
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set Eric A. Klein, Donald Richards, Allen Lee Cohn, Annals of Oncology	2021	872
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients F. Stephen Hodi, Marcus O. Butler, Darryl A. Oble, Proceedings of the National Academy of Sciences Antibody BlockadeTumor DestructionImmunologyImmune RegulationImmunoediting	2008	649
CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer Michael D. Curley, Vanessa A. Therrien, Christine L. Cummings, Stem Cells	2009	436
Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy Rocio García‐Carbonero, Jeff Supko, Judith Manola, Journal of Clinical Oncology	2004	292
Evaluation of cell-free DNA approaches for multi-cancer early detection Arash Jamshidi, Minetta C. Liu, Eric A. Klein, Cancer Cell	2022	284
Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian Cancer Zhenfeng Duan, Rosemary Foster, Debra A. Bell, Clinical Cancer Research	2006	244
Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer Lilian E. van Vlerken, Zhenfeng Duan, Michael V. Seiden, Cancer Research	2007	212
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway Deborah Chirnomas, Toshiyasu Taniguchi, Michelle de la Vega, Molecular Cancer Therapeutics	2006	206

Page 1